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Abstract
Background: In fiscal year (FY) 2008, 133,658 patients were provided services within substance use disorders
treatment programs (SUDTPs) in the U.S. Department of Veterans Affairs (VA) health care system. To improve the
effectiveness and cost-effectiveness of SUDTPs, we analyze the impacts of staffing mix on the benefits and costs of
specialty SUD services. This study demonstrates how cost-effective staffing mixes for each type of VA SUDTPs can
be defined empirically.
Methods: We used a stepwise method to derive prediction functions for benefits and costs based on patients’
treatment outcomes at VA SUDTPs nationally from 2001 to 2003, and used them to formulate optimization
problems to determine recommended staffing mixes that maximize net benefits per patient for four types of
SUDTPs by using the solver function with the Generalized Reduced Gradient algorithm in Microsoft Excel 2010
while conforming to limits of current practice. We conducted sensitivity analyses by varying the baseline severity
of addiction problems between lower (2.5 %) and higher (97.5 %) values derived from bootstrapping.
Results and conclusions: Compared to the actual staffing mixes in FY01-FY03, the recommended staffing mixes
would lower treatment costs while improving patients’ outcomes, and improved net benefits are estimated from
$1472 to $17,743 per patient.
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Background
The U.S. Department of Veterans Affairs (VA) is tasked
with providing comprehensive health care services to
Veterans within a capitated global annual budget set by
the U.S. Congress. In order to provide more effective and
cost-effective services, VA is interested in understanding
how organizational structure, staffing, and treatment
process impact patients’ health outcomes. VA treats a
large number of Veterans for substance use disorder
(SUD) in specialized SUD treatment programs (SUDTPs)
at an annual cost of more than $350 million [1]. For
example, in fiscal year 2008 (FY08), 403,117 Veterans seen
in the VA healthcare system were diagnosed with SUDs;
133,658 of them received services within VA’s specialized
SUDTPs [2]. VA operates four types of SUDTPs: inpatient,
residential, intensive outpatient and standard outpatient.
Inpatient programs provide acute, in-hospital care, detoxi-
fication and medical stabilization services. Residential and
intensive outpatient programs both focus on psychosocial
stabilization and helping patients with active SUDs
achieve a period of early abstinence, but residential pro-
grams provide a more structured setting for patients with
specific risk-factors. Residential programs provide less
medicalized services and longer lengths of stay than in-
patient programs. Intensive outpatient programs treat
patients at least 3 days per week and provide at least 3 h
of services per patient per day [3]. Standard outpatient
programs treat patients 1 to 3 days per week and provide
lower intensity ambulatory addiction treatment services,
generally focusing on relapse prevention and maintenance
of initial treatment gains in stabilized patients.
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Staffing accounts for the majority of specialty SUD
treatment costs. Thus, understanding how staffing mix
within SUDTPs impacts the benefits and costs of spe-
cialty SUD services is key to improving the effectiveness
and cost-effectiveness of treating this patient population.
Some evidence-based treatments (e.g., opioid agonist
treatment) [4] may only be delivered by staff with higher
levels of clinical training or they may be delivered with
greater adherence to protocol by staff with more clinical
training. Moreover, graduate-level training has been
found to be associated with modest but beneficial effects
on psychotherapy outcomes and retention in treatment
[5]. For these reasons, more highly trained employees
may be more effective in treating SUD patients, but they
also tend to be more expensive.
Given the differences in the treatment focus and ser-
vices required by patients in each of the four types of
SUDTPs, their staffing mixes can be quite different (e.g.,
6 % psychologists for inpatient vs. 1 % for outpatient).
This study aims to demonstrate how cost-effective staff-
ing mixes for each type of VA SUDTPs can be defined
empirically for the treatment programs.
Methods
Optimization
We identified recommended staffing mixes through the
process of optimization. Optimization involves searching
through a set of feasible solutions for one that achieves
the best value of an objective function. In our case, our
objective was to maximize net benefits per patient
within each type of SUD treatment program. Each solu-
tion corresponds to a staffing mix, the percentage of
staffing hours provided by each staff type to a patient in
a particular treatment program. A feasible staffing mix is
one that satisfies a set of constraints to ensure that it is
reasonable and conforms to the ranges observed in prac-
tice. Once potential solutions, objective function, and con-
straints are defined, standard algorithms can be used to
determine the best feasible solution. We constructed the
optimization problems in Microsoft Excel 2010 and solved
them by using the solver function with the Generalized
Reduced Gradient (GRG) algorithm to determine recom-
mended staffing mixes for each type of treatment pro-
gram. The detailed descriptions of the GRG algorithm can
be found in the following literatures [6–8].
Optimization problems have been formulated to tackle
diverse health care issues. Some examples include sched-
uling for bladder cancer patients [9, 10], determining re-
source allocation in HIV prevention programs [11–13],
and creating a portfolio of screening and contact tra-
cing for endemic diseases [14]. Optimization problems
also have been formulated to identify a better staffing
mix for high technology companies [15–17], call centers
[18, 19], and healthcare providers [20, 21]. However, we
could not find any study that addressed optimal mixes of
different types of health professionals for the context of
SUDTPs.
We set the percentages of 12 different types of staff
(e.g., psychiatrist, addiction therapists, and clerks,
Table 1) in a treatment program as the decision variable
matrix (x). We hypothesized that varying the compos-
ition of staffing x alters the benefits from the treatment
program B(x) in addition to changing staffing costs C(x).
We only considered staffing costs as a cost factor be-
cause other costs, such as facility overhead, can be
regarded as fixed and unaffected by the decision vari-
ables x and staffing costs are the major cost drivers for
SUDTPs. We determined the recommended staffing mix
x* by solving the following optimization problem:
max W ⋅ B xð Þ−C xð Þ ð1Þ
s:t:
X
x ¼ 1 ð2Þ




min Lobservedð Þ ≤ L xð Þ≤max Lobservedð Þ ð5Þ
min Hobservedð Þ ≤ H xð Þ≤max Hobservedð Þ ð6Þ
min Breasonableð Þ ≤ B xð Þ≤max Breasonableð Þ ð7Þ
Table 1 Staff types and FY01-FY03 average wages
Staff type Staff FY01-FY03 average wage ($)
Hourly Annual
Prescribers MD 75.74 157,534.22
RESMD 22.99 47,826.54
PRACT 43.70 90,891.88




Nurses RN 37.25 77,487.39
LVN 22.82 47,472.50
Support Administrators CLERC 17.84 37,113.40
AIDES 23.08 48,008.63
Trainees PDTR 10.87 22,609.48
MD: % psychiatrists or mds; RESMD: % resident physicians or fellows; PRACT: %
nurse practitioners or physicians assistants; PSYCH: % psychologists; SOCWK: %
social workers; ADTHR: % addiction therapists; OCTHR: % recreational/
occupational therapists; RN: % registered nurses; LVN: % licensed vocational/
practical nurses; CLERC: % clerical staff; AIDES: % aides/technicians; PDTR: %
paid trainees
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Equation 1 indicates that this optimization problem
aims to find a staffing mix to maximize net benefits
per patient from a treatment program. The term W de-
notes conversion factors to transform benefits derived
from treating a patient into monetary values. Some
benefits, such as increased employment earnings, are
already expressed in dollar values and thus the conver-
sion factor is 1. However, other benefits, like reduced
days with medical problems, need to be converted to
monetary values. The monetary conversion factors
were obtained from the literature and are summarized
in Table 2 [22].
The constraints for the optimization problem are
stated in Eqs 2, 3, 4, 5, 6 and 7. Equation 2 indicates that
the sum of all staff proportions should equal to 1. Equa-
tion 3 specifies that a program’s proportion for each staff
type should be in the range of those observed in treat-
ment programs, denoted by xobserved. As two examples,
standard outpatient program were run by a few as one
staff member, an addiction therapist, and most standard
outpatient programs did not have licensed vocational
nurses as more than 10 % of total staff. Equation 4 speci-
fies that the ratio of trainees (e.g., resident MDs or other
paid trainees) to supervisors (e.g., MDs or psychologists)
should fall within the observed ranges. In Eqs 5 and 6, L
and H refer to treatment length in terms of days and
treatment intensity in terms of hours per day, respect-
ively, and we limited them to be within observed pro-
gram ranges. We hypothesized that treatment length
and intensity may change depending on staffing mix,
because each type of staff provides different treatment
services requiring different treatment lengths and inten-
sities. Equation 7 restricts treatment benefits to within
possible ranges. For example, if a patient suffers from
drug problems for 20 days per month at admission, the
treatment cannot possibly reduce the patient’s days of
drug problems more than 20 days per month, nor can
patients’ days of drug problems worsen to more than
30 days per month.
Data
We derived prediction functions for benefits B(x) based
on a VA Outcomes Monitoring Project (OMP) [23] data-
base. The OMP was deemed an exempt project by the VA
Palo Alto Health Care System/Stanford University IRB.
The OMP sought to collect representative patient out-
come data by randomly selecting a sample of programs
and samples of their patients, and collected baseline and
“6-month” follow-up data on patients in VA SUDTPs in
three annual cohorts from FY01 to FY03 [23]. Compared
with the previously mandated system-wide monitoring
system, the OMP achieved a higher follow-up rate without
paying patients for their participation (67 vs. 15–21 %)
[23]. The actual follow-up point averaged 7.4 months
(SD = 2.4 months) and the follow-up rate was 65.2 %. In
all, 5548 patients in 55 standard outpatient, 36 inten-
sive outpatient, 39 residential and 14 inpatient pro-
grams were assessed at baseline, and the patients in the
methadone programs were excluded from the analysis.
A brief self-report form [24] of the Addiction Severity
Index (ASI) [25] was used to assess problems over the
past 30 days in the seven ASI domains: alcohol use,
drug use, psychiatric, medical, legal, family/social rela-
tionship, and employment problems. A cost-benefit
analysis guideline for addiction treatment using ASI
recommends including the following variables as bene-
fits: reduced number of days in a controlled envi-
ronment (medical, psychiatric, residential or hospital
substance abuse treatment program), reduced number
of days experiencing medical or psychiatric problems,
increased income received from employment, reduced
money spent on alcohol or drugs, and reduced number
of days engaged in illegal activities [22].
Unfortunately, the self-report ASI form did not in-
clude the items to assess some key benefit variables,
such as money spent on drugs and number of days en-
gaged in illegal activities of the original ASI form. Thus,
the analysis here may underestimate the benefits from
treatment programs and may explain why the net bene-
fits are estimated negative for some existing programs.
In addition, the self-report form did not specify the type
of controlled environment for each period in an environ-
ment; instead, it asked about how long a respondent
stays in all types of controlled environments and
whether the respondent stays in one or more controlled
environment during the last 30 days. Thus, we could not
use separate monetary conversion factors for each type
of controlled environments, and we needed to calculate
a ‘composite’ conversion factor for all types of controlled
environments. We counted responses to each type of
controlled environments and calculated changes in those
responses between baseline and follow-up. We used the
response changes for each type of controlled environ-
ment as weights to calculate a weighted arithmetic mean
of the monetary conversion factors of all types of con-
trolled environments, a ‘composite’ factor to convert
reductions in days in all types of controlled environ-
ments into monetary benefits from a treatment.
The OMP also assessed VA SUDTPs’ characteristics,
staff mix and services delivered via a program survey
[23]. The survey gathered additional information on staff
(e.g., time spent in group and individual treatment) to
better assess program costs [23].
Influence diagrams
Influence diagrams [26, 27] were used to specify likely po-
tential relationships among variables affected by staffing
mix and highlight each treatment program’s characteristics.
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Table 2 Benefit prediction functions









32.143–0.975*(BASELINE ALCOHOL CONSUMPTION) 0.779 $150.75 1.00
Employment
earning
66.806–0.935*(BASELINE EMPLOYMENT EARNING) + 1354.584*MD 0.532 $145.40 1.00
Days with medical
problem




10.648–0.599*(BASELINE PSYCHOLOGICAL PROBLEM)-9.659*RN 0.303 14.96 days $10.21/day
Days with drug
problem
3.245–0.929*(BASELINE DRUG PROBLEM)-9.146*LVN 0.735 10.59 days $18.33/day
Days with alcohol
problem
2.588–0.881*(BASELINE ALCOHOL PROBLEM) 0.578 12.35 days $18.33/day
Days in controlled
environment

















6.983–0.714*(BASELINE PSYCH PROBLEM) + 17.109*PDTR-82.503*RESMD 0.380 10.63 days $10.21/day
Days with drug
problem
0.722–0.834*(BASELINE DRUG PROBLEM) + 15.673*PDTR 0.633 7.01 days $18.33/day
Days with alcohol
problem
1.947–0.875*(BASELINE ALCOHOL PROBLEM) 0.600 8.87 days $18.33/day
Days in controlled
environment
2.487–0.909*(BASELINE CONTROLLED ENVIRONMENT) + 0.081*(TREATMENT
LENGTH) +9.428*LVN





20.851–0.993*(BASELINE ALCOHOL CONSUMPTION) 0.773 $93.56 1.00
Employment
earning
117.034–0.679*(BASELINE EMPLOYMENT EARNING) + 910.813*PSYCH 0.312 $248.35 1.00
Days with medical
problem




7.564–0.718*(BASELINE PSYCH PROBLEM)-11.269*AIDES 0.380 11.84 days $10.21/day
Days with drug
problem
0.954–0.833*(BASELINE DRUG PROBLEM) 0.625 6.87 days $18.33/day
Days with alcohol
problem
2.635–0.869*(BASELINE ALCOHOL PROBLEM)-10.109*PSYCH 0.621 8.57 days $18.33/day
Days in controlled
environment















8.875–0.591*(BASELINE MEDICAL PROBLEM) + 0.327*(TREATMENT INTENSITY)-
24.052*PDTR
0.304 12.55 days $26.44/day
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In influence diagrams, a decision, such as staffing mix, is
represented as a rectangle, and an uncertainty quantity,
such as patient health status, is represented as an oval. A
double oval represents a variable that is a deterministic
function of its inputs, such as hourly staffing cost, and a
diamond refers to the objective function, such as net bene-
fit. Arcs represent possible conditional dependence among
quantities [26, 27]. For example, having no arc from staffing
mix to total staffing cost per patient indicates that they are
conditionally independent, given hourly staffing costs.
We formulated the hypothetical influence diagram in
Fig. 1 based on the variables that are assessed in the
OMP database assuming no conditional independence.
The hypothetical model shows how staffing mix is
believed to affect patient status after treatment. We
allowed treatment length and intensity to change de-
pending on the staffing mix. We also allowed treatment
intensity and length to affect patient status after treat-
ment and those treatment factors to be tailored to the
baseline characteristics of patients (e.g., more severe
patients would be treated longer). Treatment length was
allowed to depend on treatment intensity (e.g., more in-
tense treatments might be provided for shorter periods).
Total staffing costs were calculated by multiplying
hourly staffing cost, treatment intensity, and treatment
length. Benefits from treating a patient were calculated
by subtracting baseline patient status from patient status
at follow-up, and total benefits were calculated by multi-
plying benefits with the average follow-up point (e.g.,
7.4 months) [22]. Net benefits are total benefits less total
staffing costs.
Based on the hypothetical influence diagram, we ex-
amined the correlations among variables for each type of
program, and whenever there was any nonzero correl-
ation between two variables at the significance level of
0.05, we included an arc between them. The correlations
among variables also can be found from prediction func-
tions in the following section; however, influence dia-
grams graphically present the relations among variables
more clearly.




6.503–0.641*(BASELINE PSYCH PROBLEM) + 0.221*(TREATMENT INTENSITY) +
27.111*LVN
0.341 11.87 days $10.21/day
Days with drug
problem
0.797–0.865*(BASELINE DRUG PROBLEM) + 2.572*PRACT + 17.56*LVN 0.625 4.88 days $18.33/day
Days with alcohol
problem
2.812–0.809*(BASELINE ALCOHOL PROBLEM)-8.044*PSYCH-4.518*RN 0.531 6.97 days $18.33/day
Days in controlled
environment
4.502–0.836*(BASELINE CONTROLLED ENVIRONMENT)-6.965*SOCWK +
14.917*OCTHR
0.405 6.49 days $18.33/day
MD: % psychiatrists or mds; RESMD: % resident physicians or fellows; PRACT: % nurse practitioners or physicians assistants; PSYCH: % psychologists; socwk: %
social workers; ADTHR: % addiction therapists; OCTHR: % recreational/occupational therapists; RN: % registered nurses; LVN: % licensed vocational/practical nurses;
CLERC: % clerical staff; AIDES: % aides/technicians; PDTR: % paid trainees
Fig. 1 Influence diagram for VA SUD treatment program assuming no conditional independence
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Prediction functions
We derived prediction functions for benefits (Table 2)
by using a stepwise method. The same covariates were
included in prediction functions derived from other
methods (e.g., backward method), and coefficients of the
covariates were almost identical. For some types of treat-
ment programs, baseline patient status and staff vari-
ables were the only covariates to predict benefits, but for
others treatment intensity and length have predictive
power as presented in Fig. 2. We did not find any signifi-
cant correlations among the staff variables and did not
include any interactions between staff variables in deriv-
ing prediction functions. For all benefit prediction func-
tions, baseline patient status appeared to be a major
benefit driver, and if a patient came to treatment when
he or she was in a more serious status, changes in pa-
tient status between before and after treatments were
likely to be larger (as would be expected from regression
to the mean). For the base analysis, we used average
patient status values and then varied them in sensitivity
analyses. We also derived prediction functions for staff-
ing cost factors (treatment intensity and treatment
length) (Table 3) by using a stepwise method and veri-
fied them with other methods. Hourly staffing cost is a
weighted arithmetic mean of different types of staffs’ ac-
tual costs [28], and only treatment intensity and treat-
ment length needed to be predicted with staff and
baseline patient status covariates (Table 3). Treatment
length for standard and intensive outpatient programs
could not be predicted with enough predictive power
(e.g., adjusted R2 less than 0.10); thus, the average con-
stant values of those cost factors were used for the ana-
lysis. All statistical analyses were conducted using PASW




Based on data from OMP [23], Table 4 provides the
characteristics of patients admitted to each type of treat-
ment program, as well as information on treatment in-
tensity (i.e., hours per day) and length (i.e., days) of
those programs. The programs are listed in decreasing
order of the severity of patients’ conditions, treatment
intensity, and (more or less) in increasing order of the
treatment length. Not surprisingly, standard and inten-
sive outpatient programs provided more lengthy treat-
ment services.
Fig. 2 Influence diagrams of VA SUD treatment programs
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Influence diagrams
Figure 2 summarizes the influence diagrams for the four
types of SUDTPs. In all program types, staffing mix was
associated with treatment intensity and patient outcome
after treatment, but staffing mix was related to treatment
length only in inpatient and residential programs. This
implies that treatment intensities and patient outcomes
of all SUDTPs may depend on their staffing mixes which
also determine treatment lengths of inpatient and
residential programs. Patient status before treatment was
associated with treatment intensity in residential, inten-
sive outpatient, and standard outpatient programs,
suggesting that these types of programs tailor treatment
intensity based on patient status at the start of care.
Conversely, there was no relationship between patient
status before treatment and treatment length in intensive
outpatient and standard outpatient programs. Presum-
ably, these programs titrate treatment exposure based on
patient response to care (e.g., success in achieving initial
abstinence or medical stability), rather than patients’ ini-
tial state. In other words, these outpatient programs try
to keep patients in treatment until they get better, rather
than setting treatment duration based on illness severity
at intake. Notably, treatment intensity and length were
Table 3 Prediction functions for treatment intensity and treatment length
Cost factor Prediction function Adj. R2
24 h care Inpatient Treatment intensity
(hours/day)
12.146–452.776*RESMD-8.568*RN + 124.438*CLERC + 187.722*PDTR-69.657*SOCWK-









0.594 + 161.368*RESMD + 7.160*AIDES + 7.131*RN + 10.740*PRACT + 11.241*MD-4.762*SOCWK





65.688–208.151*PRACT + 392.280*OCTHR + 257.058*MD-892.674*RESMD-191.554*PDTR-
72.917*CLERC-57.393*RN −57.240*SOCWK + 0.582*(BASELINE CONTROLLED ENVIRONMENT)-
0.008*(BASELINE EMPLOYMENT EARNING) −0.248*(BASELINE MEDICAL PROBLEM)
0.195
Outpatient Intensive Treatment intensity
(hours/day)
5.002 + 23.378*PRACT-10.074*LVN-20.253*PSYCH + 7.961*PDTR-7.992*SOCWK + 7.700*OCTHR +




97.435–0.797*(BASELINE DRUG PROBLEM)-103.899*RN-110.129*RESMD 0.026
Standard Treatment intensity
(hours/day)
3.604 + 8.185*PRACT-3.924*ADTHR-4.250*AIDES-4.325*CLERC + 6.289*RESMD + 4.266*PSYCH +




59.413 + 0.819*(BASELINE CONTROLLED ENVIRONMENT) + 333.825*PDTR + 45.783*PRACT +
310.603*LVN
0.022
MD: % psychiatrists or mds; RESMD: % resident physicians or fellows; PRACT: % nurse practitioners or physicians assistants; PSYCH: % psychologists; SOCWK: %
social workers; ADTHR: % addiction therapists; OCTHR: % recreational/occupational therapists; RN: % registered nurses; LVN: % licensed vocational/practical nurses;
CLERC: % clerical staff; AIDES: % aides/technicians; PDTR: % paid trainees
Table 4 Patient status when admitted to four type of treatment programs, and treatment intensity and length of the programs
Inpatient Residential Intensive outpatient Standard outpatient
(N = 603) (N = 1763) (N = 1374) (N = 1808)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Patient status when admitted Employment earnings ($/month) 145.40 (426.99) 214.47 (618.91) 248.35 (634.06) 315.62 (914.15)
Alcohol consumption ($/month) 150.75 (264.02) 93.41 (202.06) 93.56 (216.71) 73.28 (220.18)
Days with medical problems
(days/month)
13.51 (13.25) 11.47 (13.08) 11.79 (13.15) 12.55 (13.32)
Days with psychological problems
(days/month)
14.96 (12.14) 10.63 (11.92) 11.84 (12.22) 11.87 (12.27)
Days with drug problems
(days/month)
10.59 (12.45) 7.01 (10.74) 6.87 (10.66) 4.88 (9.60)
Days with alcohol problems
(days/month)
12.35 (12.22) 8.87 (11.31) 8.57 (11.36) 6.97 (10.55)
Days in controlled environments
(e.g. jail) (days/month)
7.77 (9.11) 10.15 (11.11) 8.21 (10.22) 6.49 (10.32)
Treatment administration Treatment intensity (hours/day) 6.10 (3.56) 3.88 (3.09) 3.26 (4.77) 3.03 (3.63)
Treatment length (days) 33.27 (40.03) 57.98 (62.48) 74.24 (93.33) 72.56 (113.03)
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not associated with patient status at follow-up within in-
tensive outpatient and inpatient programs. Thus, for
these program types, lengthier treatments were not asso-
ciated with greater improvement in patients’ outcomes,
but they were more costly. For inpatient and residential
programs, treatment length was negatively associated
with treatment intensity (e.g., more intense treatments
were provided for shorter periods), whereas there was
no significant correlation for intensive and standard out-
patient programs.
Actual versus suggested staffing mix for treatment
programs
The actual staffing mixes in FY01-FY03 for different
types of SUDTPs were not significantly different, al-
though there was substantial variation in staffing mix
within each type of SUDTP (Table 5). Table 5 summa-
rizes actual staffing patterns in FY01-FY03 and com-
pares them to staffing mixes suggested by solving the
optimization problem for the four types of SUDTPs. The
summaries and comparisons in Table 5 are visualized in
Fig. 3.
The suggested staffing mix of inpatient programs in-
cludes more MDs or psychiatrists than other treatment
programs, likely reflecting the medical orientation of
such programs. However, MDs or psychiatrists typically
are more expensive to employ than other types of pre-
scribers (e.g., resident MDs and nurse practitioners). In
contrast, for residential and intensive outpatient pro-
grams, suggested staffing mixes are redistributed to less
expensive staff members who can perform similar func-
tions. The model suggests it would be cost-effective to
increase proportions of nurse practitioners who might
function similarly to MDs or psychiatrists as prescribers.
Interestingly, such changes increase patient benefits in
addition to reducing costs. For residential and intensive
outpatient programs, more psychologists were recom-
mended. Although psychologists are more expensive
than other psychosocial rehabilitators (e.g., social
workers, addiction therapists, and occupational thera-
pists), they more strongly increase patients’ earnings
from employment and reduce their days with alcohol
problems, with the value of those benefits being larger
than the costs to achieve them. The suggested staffing
mix of inpatient programs would involve hiring more li-
censed vocational nurses than registered nurses; how-
ever, the recommendation for residential programs is the
opposite.
In intensive outpatient programs, although psycholo-
gists are more expensive than other psychosocial rehabili-
tators, they increase patients’ earnings from employment
and reduce their days with alcohol problems, with the
value of those benefits outweighing the costs to achieve
them. The suggested staffing of standard outpatient pro-
grams would involve hiring more administrative staff and
paid trainees, potentially indicating that during the FY01-
Table 5 Actual and suggested optimal staffing mix for VA SUDTPs
Staff Inpatient Residential Intensive outpatient Standard outpatient
Actual Suggested Actual Suggested Actual Suggested Actual Suggested
FY01-FY03 FY01-FY03 FY01-FY03 FY01-FY03
mean % (SD) % mean % (SD) % mean % (SD) % mean % (SD) %
MD 7.41 (5.11) 19.87 5.39 (3.97) 0.80 7.06 (8.29) 0.00 8.56 (9.53) 0.00
RESMD 0.41 (1.24) 0.00 0.22 (0.85) 0.53 4.11 (7.93) 0.00 2.85 (5.60) 0.00
PRACT 6.44 (9.29) 0.00 5.99 (6.60) 14.50 7.65 (15.58) 8.55 9.12 (20.44) 0.00
PSYCH 5.55 (9.65) 5.75 5.49 (4.46) 15.00 8.51 (8.74) 33.33 7.01 (7.53) 0.74
SOCWK 10.09 (8.60) 29.63 12.50 (7.82) 28.57 9.14 (8.32) 0.00 11.95 (12.30) 8.29
ADTHR 12.46 (11.16) 0.00 26.77 (23.25) 11.37 29.74 (17.56) 0.00 29.63 (25.86) 0.00
OCTHR 3.36 (2.76) 6.95 3.43 (3.22) 0.00 2.85 (4.19) 0.00 2.08 (5.11) 0.00
RN 22.64 (14.91) 0.00 10.44 (9.18) 29.22 14.17 (10.22) 0.00 11.23 (12.34) 0.00
LVN 15.79 (12.95) 32.06 3.18 (8.23) 0.00 2.20 (6.66) 0.00 0.72 (2.49) 0.00
CLERC 5.20 (3.32) 0.00 7.24 (5.61) 0.00 4.94 (4.56) 0.00 11.77 (9.61) 29.41
AIDES 9.78 (12.96) 0.00 17.47 (20.16) 0.00 4.88 (9.73) 33.12 3.59 (12.90) 46.81
PDTR 0.88 (1.91) 5.75 1.88 (4.36) 0.00 4.75 (8.07) 25.00 1.49 (3.13) 14.75
Benefits ($) 5989.96 14,808.92 5888.00 17,904.42 3179.05 10,319.39 1330.67 2136.45
Costs ($) 6286.93 298.46 7408.10 161.05 9072.54 1012.52 8140.95 664.27
Net benefits ($) −296.97 14,510.46 −1520.10 17,743.37 −5893.49 9306.87 −6810.28 1472.18
MD: % psychiatrists or mds; RESMD: % resident physicians or fellows; PRACT: % nurse practitioners or physicians assistants; PSYCH: % psychologists; SOCWK: %
social workers; ADTHR: % addiction therapists; OCTHR: % recreational/occupational therapists; RN: % registered nurses; LVN: % licensed vocational/practical nurses;
CLERC: % clerical staff; AIDES: % aides/technicians; PDTR: % paid trainees
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03 period some more expensive VA clinical staff may have
been performing functions that could have been effectively
completed by less costly administrative staff or trainees.
At the suggested staffing mixes, net benefits from the
treatment programs become positive. While benefits
from treating a patient would be expected to increase,
total staffing costs would decrease drastically under the
suggested staffing mixes. Suggested staffing mixes are
directed at minimizing total treatment hours in addition
to hourly staffing costs, while maintaining treatment
effectiveness.
Sensitivity analyses
Sensitivity analyses were conducted to check the robust-
ness of the results described in the previous section.
First, we varied the monetary conversion factors for days
with drug and alcohol problems. The self-report ASI
asked only about number of days having drug or alcohol
problems, but it did not specify whether those problems
are physical or psychological ones. Thus, we used an
average value of the monetary conversion factors for
medical and psychological problems from prior research
[21] for the base analysis, and then varied it within both
ranges in the sensitivity analyses. The sensitivity analysis
showed that the optimal staffing mixes for all treatment
programs are insensitive to changes in the monetary
conversion factor. In addition, we varied baseline sever-
ity of addiction problems in treatment patients; in
addition to the mean values of addiction problem sever-
ity, we used lower (2.5 %) and higher (97.5 %) patient
baseline addiction problem severity values derived from
bootstrapping. The sensitivity analysis demonstrated that
the originally calculated optimal staffing mixes are not
sensitive to changes in baseline patient addiction prob-
lem severity, although, as expected, we observed that
when a patient starts with more serious addiction prob-
lems, the derived benefits (and net benefits) from treat-
ing the patient are greater.
Discussion
Recommended staffing mixes for substance use disorder
treatment programs differ depending on the type of
Fig. 3 Actual and suggested optimal staffing mix for VA SUDTPs
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program. Given the differences in focus and the
intended population of the programs, this was expected.
The staffing requirements or licensure/accreditation re-
quirement for each type of programs were already
reflected since observed ranges were used as constraints
in the optimization problems. With the modeled opti-
mized staffing mixes, we found that treatment intensity
and length would be substantially shorter than average
values. Thus, optimizing staffing mixes could not only
increase net benefits of the treatment programs, but
could also reduce treatment time. Reductions in treat-
ment time would allow VA SUDTPs to treat more pa-
tients with the same number of staff, bringing SUD
treatment benefits to more Veteran patients and poten-
tially improving access and reducing wait-times for care.
Encouragingly, recommended outpatient staff mix rec-
ommendations appear in line with treatment goals at
various stages of treatment. Specifically, a main goal of
intensive outpatient care is to help SUD patients who
are actively using or at high risk of relapse to achieve an
initial period of stable abstinence. Evidence-based SUD
psychotherapy and pharmacotherapy protocols would
thus be expected to dominate effective care directed to-
ward this goal [29, 30]. We recommend staffing these
programs with psychologists, aides and nurse practi-
tioners/physician assistants (NPs/PAs), and eliminating
other psychosocial rehabilitators, medical doctors (MDs)
and other nursing staff. Notably, psychologists should be
optimally trained to deliver the evidence-based psycho-
therapy protocols shown in randomized controlled trials
to be effective for achieving abstinence. Unlike other
nurses, NPs/PAs are able to prescribe medications for
alcohol use disorder pharmacotherapy and co-morbid
mental health disorders, and can do so at lower cost
than MDs. Because of their lower cost, NPs/PAs may be
able to spend more time with patients than MDs, which
may be beneficial for developing treatment plans and
delivering treatments to modify behaviors.
In contrast, a main goal of standard outpatient pro-
grams is to help patients maintain abstinence once they
are stabilized. Maintaining case-management and con-
tact with recovery-focused services, such as mutual help
groups, and addressing psychiatric co-morbidities and
psychosocial issues that may increase risk of relapse has
been shown to be important for maintaining abstinence
[31–36]. In these programs, our model suggests staffing
primarily with social workers with lower percentages of
psychologists and higher percentages of administrative
staff. Monitoring abstinence, encouraging recovery-
focused activities, and case management are all within
the training of social workers and these staff are substan-
tially less expensive than psychologists.
Compared to other methods (e.g., measuring clinician
productivity), our approach to optimal staffing captures
the importance of staff members, such as clerks, who do
not provide direct patient care for achieving both greater
efficiency and better patient outcomes. Results of a re-
cent survey of VA SUDTPs suggest that support staff
may be crucially important for retaining other program
staff and thus maintaining efficient delivery of SUD
treatment. Specifically, the FY10 VA Drug and Alcohol
Program Survey found that after retirement and promo-
tion, the most frequent reason cited for loss of staff from
SUD treatment programs in the previous year was “ex-
cess administrative burden” [37]. Increasing support staff
may be an efficient and effective intervention to help
clinical staff focus more on treating SUD patients, po-
tentially improving treatment outcomes while limiting
program costs.
The recommended intensive outpatient program staff-
ing eliminates medical doctors, including psychiatrists
and residents, from these programs and greatly increases
staffing with paid trainees and aides. Although medical
doctors had some beneficial impact on psychological
outcomes, they did not have a significant impact on al-
cohol and substance use and other outcomes considered
in these analyses. We note that these findings must be
interpreted within the context of practice patterns in VA
SUDTPs in FY01-FY03. Buprenorphine-based opioid
agonist treatment is a highly effective outpatient treat-
ment for opioid dependence that was approved by the
U.S. Federal Drug Administration in 2002, and NP/PAs
cannot prescribe buprenorphine for the treatment of
opioid dependence (e.g. SAMHSA, DATA 2000 http://
buprenorphine.samhsa.gov/data.html). At the time the
data analyzed here were collected, SUDTPs rarely pro-
vided effective pharmacotherapies for substance use dis-
orders to patients. Opioid agonist treatment for opioid
dependence was offered in separate methadone mainten-
ance clinics and pharmacotherapy for alcohol use disor-
ders was provided to only 3 % of patients with an
alcohol use disorder nationally [38]. Increasing use of
evidence-based pharmacotherapies by medical doctors
may increase the beneficial effects of such staff on sub-
stance use and associated problems (e.g., illegal activity
and risk of being in a controlled environment). Reevalu-
ation of the recommendation to eliminate medical
doctors in intensive outpatient programs is warranted in
programs where opioid agonist treatment with buprenor-
phine and effective alcohol pharmacotherapies are regularly
prescribed. Nevertheless, these findings emphasize that, at
least in the absence of use of SUD pharmacotherapies,
medical doctors do not provide benefits that justify their
cost in programs focused on early outpatient stabilization
and achieving initial abstinence. Likewise, since FY01-FY03,
VA has greatly increased focus on training and provision of
evidence-based psychotherapies within its mental health
programs. Use of these evidence-based therapies may
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substantially increase treatment benefits of patients, and
paid trainees and aides may not be able to reliably deliver
these therapies. Additionally, not all VA medical centers
have training programs, and thus, although the model rec-
ommendations are within the range observed in VA SUD
programs in FY01-FY03, they may need to be reconsidered
in the context of current care practices and facility context.
Reconfiguring staffing mix in SUDTPs may be feasible
through natural attrition. In general, turnover among
mental health service providers is high, typically between
25–50 % per year, which, although detrimental for treat-
ment access, implementation of evidence-based treat-
ments, and quality of care, provides opportunities to
restructure treatment program staffing relatively rapidly
[39–46]. In addition, many VA employees are entering
retirement age. Beneficially, many medical centers in-
clude clinical training programs that together train over
100,000 health professionals per year. For example, 70 %
of U.S. physicians have received at least some of their
training at VA hospitals [47]. These training programs
provide a large pool of new health professionals who
could be rapidly integrated into VA SUDTPs. Therefore,
it may be feasible to implement optimized staffing mixes
in real-world settings.
Limitations
First, this analysis is based upon program staffing and
practice patterns and patient outcomes in FY01-FY03.
Although this time period is that for which the most
recent VA system-wide patient substance use disorder
treatment outcomes data are available, the system has
been changed since that time by numerous national,
regional, and local quality improvement efforts, dramatic
expansion of mental health staffing, increases in VA
enrollees, and gradual shifts in the demographics and
mix of substance use disorder diagnoses among VA pa-
tient populations [48]; in addition, there has been many
new innovations that had been implemented such as the
use of computer simulations to help people who are di-
agnosed with PTSD since the period. Ideally, the ana-
lyses reported here would be repeated using outcomes
data from more recent SUDTP patients. Second, the
present analyses include only VA SUDTPs and the find-
ings may not generalize to other treatment settings. VA
SUDTPs generally treat a population predominated by
older male patients with chronic substance use disorders
and high rates of psychiatric co-morbidity. Third, since
FY01-FY03, there has been a trend toward restructuring
SUDTPs at VA medical centers, such that inpatient, resi-
dential, intensive outpatient and standard outpatient
care is combined into a single umbrella program. It is
not immediately clear from these analyses how to
optimize staff mix in such mixed-purpose programs;
however, one might reasonably expect the staffing
recommendations to hold for components of these
mixed programs with the same treatment focus and
goals as the program types studied here. Finally, these
analyses lacked some estimates such as reductions in
spending on drugs and in time engaged in illegal activ-
ities in the benefit calculations. Thus, these analyses
almost certainly underestimate treatment benefits at
6 months. These analyses also do not include estimates
of longer-term benefits since the actual follow-up of
patients is very short (e.g., 7.4 months), which may be
particularly important for optimizing staffing mix in
standard outpatient programs, where the focus is on re-
lapse prevention and fostering recovery.
Conclusions
There has been no systematic empirical method for
staffing SUDTPs. The approach reported here provides a
rational basis for staffing SUDTPs in a way that effi-
ciently maximizes benefits for patients. This approach
also provides a framework to systematically incorporate
characteristics of the intended patient population into
staffing decisions at SUDTPs. Given the availability of
collected patient outcomes data, this approach provides
a systematic method to guide SUDTP staffing based on
the patient benefits, staffing costs, and dynamics of the
treated patient population.
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